Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-aging compounds from Dengzhan Shengmai formulation
PLOS One · 2026
DOI: 10.1371/journal.pone.0356888 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Jingyi Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Province Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical University, Chengde, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Aging, Artificial Intelligence. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Start-up Fund for High-level Talents of Chengde Medical University, Central Government-Guided Local Science and Technology Development Fund Project.
Abstract (Originalsprache)
Aging is a complex biological process involving multiple dysregulated pathways, and synergistic compound combinations offer distinct therapeutic advantages through multi-target and multi-pathway interactions. Traditional Chinese Medicine (TCM) formulations are inherently synergistic, yet systematically identifying their active anti-aging combinations remains a major challenge. Here, we developed DeepSMCA, a deep learning-based framework integrating molecular descriptors, ADMET parameters, and protein-protein interaction (PPI) network embeddings learned via a variational graph auto-encoder (VGAE), combined with a ResNetDNN classifier and the Bliss independence model, to identify synergistic combinations of anti-aging compound from the Dengzhan Shengmai (DZSM) formulation. Trained on 914 curated compounds, DeepSMCA achieved an area under the curve (AUC) of 0.9849 on the validation set, outperforming conventional machine learning and deep learning baselines, and interpretability analysis revealed that PPI network features contributed most (59.5%) to model predictions. Chemical profiling identified 30 constituents in DZSM, from which the three top-ranked synergistic combinations (Com1–3) were validated in D-galactose (D-Gal)-induced senescent PC12 cells. All three combinations enhanced cell viability, alleviated oxidative stress, attenuated intracellular reactive oxygen species accumulation, and decreased senescence-associated β -galactosidase-positive cells by up to 54.79%. Transcriptomic analysis showed that the combinations reversed 1,001–1,037 D-Gal-induced differentially expressed genes (DEGs), which were enriched in 18 shared aging-related pathways centered on longevity regulation, FoxO, p53, and autophagy signaling. Compound-target–aging-pathway network analysis further revealed complementary target engagement among constituents. This study establishes an interpretable, proof-of-concept computational–experimental pipeline for dissecting multi-component synergy in complex formulations, providing a generalizable strategy for anti-aging drug discovery from TCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hebei Province Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical University, Chengde, China.
- Chengde Medical University, Chengde, China.
- Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
- Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, Hebei, China.
ORCID-Profile: Jingyi Hou
Förderung
- National Natural Science Foundation of China
- Research Start-up Fund for High-level Talents of Chengde Medical University
- Central Government-Guided Local Science and Technology Development Fund Project
- Chengde Applied Technology Research and Development Project
- Hebei Natural Science Foundation
- Science Research Project of Hebei Education Department
Zitieren
APA
Hou, J., Li, X., Gu, M., Ding, K., Yang, K., & Xu, B. (2026). Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-aging compounds from Dengzhan Shengmai formulation. PLOS One. https://doi.org/10.1371/journal.pone.0356888
Vancouver
Hou J, Li X, Gu M, Ding K, Yang K, Xu B. Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-aging compounds from Dengzhan Shengmai formulation. PLOS One. 2026. doi:10.1371/journal.pone.0356888
BibTeX
@article{Hou2026,
author = {Hou, Jingyi and Li, Xueli and Gu, Miao and Ding, Kaikai and Yang, Kailan and Xu, Bowen},
title = {Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-aging compounds from Dengzhan Shengmai formulation},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0356888}
}
EUVIMED